+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Facial Injectables Market by Product Type, Treatment Area, End User, Distribution Channel, Application Method, Age Group - Global Forecast to 2030- Product Image
Facial Injectables Market by Product Type, Treatment Area, End User, Distribution Channel, Application Method, Age Group - Global Forecast to 2030- Product Image
Sale

Facial Injectables Market by Product Type, Treatment Area, End User, Distribution Channel, Application Method, Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4995152
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Facial injectables represent a rapidly evolving sector within aesthetic medicine, transforming both patient expectations and clinical practices. With major advances in formulation, digital engagement, and global distribution, key stakeholders must navigate an increasingly complex landscape to capture future growth and endure competitive pressures.

Market Snapshot: Facial Injectables Market Overview

The Facial Injectables Market grew from USD 19.30 billion in 2024 to USD 21.63 billion in 2025. It is expected to continue growing at a CAGR of 11.83%, reaching USD 37.76 billion by 2030. Market expansion is driven by continuous innovation in neurotoxins and dermal fillers, the broadening appeal to wider age groups, and the integration of digital channels for patient consultation and support. Heightened demand is supported by both established and emerging markets, leading to robust adoption and expanded competition worldwide.

Scope & Segmentation

  • Product Types: Botulinum toxins (AbobotulinumtoxinA, IncobotulinumtoxinA, OnabotulinumtoxinA), dermal fillers such as calcium hydroxylapatite, collagen, hyaluronic acid, and poly-L-lactic acid.
  • Treatment Areas: Cheek augmentation, crow’s feet, forehead lines, glabella lines, lip augmentation, and nasolabial folds.
  • End Users: Dermatology clinics, hospitals, medical spas, plastic surgery clinics.
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies, specialty clinics.
  • Application Methods: Microcannula and needle injection techniques.
  • Age Groups: 30 to 50, over 50, and under 30.
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific; further broken down to key countries such as the United States, Canada, Brazil, United Kingdom, Germany, Japan, China, India, and more.
  • Leading Companies: AbbVie Inc., Galderma S.A., Merz Pharma GmbH & Co. KGaA, Ipsen S.A., Revance Therapeutics, Inc., Evolus, Inc., Daewoong Pharmaceutical Co., Ltd., Medytox Inc., Hugel, Inc., Suneva Medical, Inc.

Key Takeaways for Senior Decision-Makers

  • Technological innovation is driving next-generation products—neurotoxins with extended durability and bioactive fillers—supporting more personalized and longer-lasting treatment outcomes.
  • Consumer demographics are diversifying as preventative and enhancement procedures attract both younger and established patient segments, expanding the total addressable market.
  • Digital transformation—including AI-driven treatment planning and e-commerce for aftercare—has become a core strategy for acquisition and long-term patient engagement.
  • Brand differentiation increasingly depends on clinical data transparency, sustainable practices, and the ability to align with local regulatory and cultural expectations.
  • Collaborations with clinical research centers and digital distribution excellence are fundamental to building competitive advantage and market share.
  • Outcome tracking and real-world data integration are critical to demonstrating sustained efficacy and safety, reinforcing value propositions with both providers and patients.

Tariff Impact on the Facial Injectables Market

Shifts in 2025 tariff structures on imported ingredients and finished injectables are raising supply chain costs and prompting strategic realignment. Manufacturers have accelerated near-shoring, diversified sourcing, and invested in domestic capacities to stabilize pricing and maintain competitiveness. These responses favor companies with strong procurement strategies, supply chain flexibility, and transparent cost governance, supporting continued access and resilience across distributor networks.

Methodology & Data Sources

Insights draw from a balanced mix of secondary sources, including industry publications, regulatory documentation, and company reports, alongside primary research with clinicians, distributors, and end-users. Data triangulation and scenario analysis ensure a coherent view of evolving technologies, procedural trends, and potential supply chain risks. Ethical standards and confidentiality were foundational throughout the research process.

Why This Report Matters

  • Enables stakeholders to align R&D, distribution, and marketing strategies with emerging trends and evolving regulations.
  • Delivers actionable guidance for tariff navigation, segmentation, and regional market penetration, supporting evidence-based investment decisions.
  • Facilitates benchmarking against leading innovators to help shape sustained, competitive business models in the global facial injectables sector.

Conclusion

The evolution of the facial injectables market is defined by advancing technologies, market segmentation, and global expansion. Staying informed on tariff impacts, consumer dynamics, and sustainability priorities will be essential for decision-makers aiming to secure growth, operational agility, and enduring customer trust.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Facial Injectables Market, by Product Type
8.1. Introduction
8.2. Botulinum Toxin
8.2.1. AbobotulinumtoxinA
8.2.2. IncobotulinumtoxinA
8.2.3. OnabotulinumtoxinA
8.3. Dermal Fillers
8.3.1. Calcium Hydroxylapatite
8.3.2. Collagen
8.3.3. Hyaluronic Acid
8.3.4. Poly-L-Lactic Acid
9. Facial Injectables Market, by Treatment Area
9.1. Introduction
9.2. Cheeks Augmentation
9.3. Crow'S Feet
9.4. Forehead Lines
9.5. Glabella Lines
9.6. Lips Augmentation
9.7. Nasolabial Folds
10. Facial Injectables Market, by End User
10.1. Introduction
10.2. Dermatology Clinics
10.3. Hospitals
10.4. Medical Spas
10.5. Plastic Surgery Clinics
11. Facial Injectables Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
11.5. Specialty Clinics
12. Facial Injectables Market, by Application Method
12.1. Introduction
12.2. Microcannula Injection
12.3. Needle Injection
13. Facial Injectables Market, by Age Group
13.1. Introduction
13.2. 30 to 50
13.3. Over 50
13.4. Under 30
14. Americas Facial Injectables Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Facial Injectables Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Facial Injectables Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AbbVie Inc.
17.3.2. Galderma S.A.
17.3.3. Merz Pharma GmbH & Co. KGaA
17.3.4. Ipsen S.A.
17.3.5. Revance Therapeutics, Inc.
17.3.6. Evolus, Inc.
17.3.7. Daewoong Pharmaceutical Co., Ltd.
17.3.8. Medytox Inc.
17.3.9. Hugel, Inc.
17.3.10. Suneva Medical, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. FACIAL INJECTABLES MARKET MULTI-CURRENCY
FIGURE 2. FACIAL INJECTABLES MARKET MULTI-LANGUAGE
FIGURE 3. FACIAL INJECTABLES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL FACIAL INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2030 (%)
FIGURE 16. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. FACIAL INJECTABLES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. FACIAL INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. FACIAL INJECTABLES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FACIAL INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ABOBOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY INCOBOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ONABOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY CALCIUM HYDROXYLAPATITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY CHEEKS AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY CROW'S FEET, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY FOREHEAD LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY GLABELLA LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY LIPS AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY NASOLABIAL FOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY PLASTIC SURGERY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY MICROCANNULA INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY NEEDLE INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY 30 TO 50, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY OVER 50, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY UNDER 30, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. CANADA FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. CANADA FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 62. CANADA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 63. CANADA FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 64. CANADA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. CANADA FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. CANADA FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 67. CANADA FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. MEXICO FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. MEXICO FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 70. MEXICO FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 72. MEXICO FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. MEXICO FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. MEXICO FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 75. MEXICO FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 109. GERMANY FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. GERMANY FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 111. GERMANY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 112. GERMANY FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 113. GERMANY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. GERMANY FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. GERMANY FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 116. GERMANY FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 117. FRANCE FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. FRANCE FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 119. FRANCE FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 120. FRANCE FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 121. FRANCE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. FRANCE FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 124. FRANCE FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 133. ITALY FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. ITALY FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 135. ITALY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 136. ITALY FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 137. ITALY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. ITALY FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. ITALY FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 140. ITALY FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. SPAIN FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. SPAIN FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 143. SPAIN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 144. SPAIN FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 145. SPAIN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. SPAIN FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. SPAIN FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 148. SPAIN FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 173. DENMARK FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. DENMARK FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 175. DENMARK FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 176. DENMARK FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 177. DENMARK FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. DENMARK FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. DENMARK FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 180. DENMARK FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 188. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 189. QATAR FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. QATAR FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 191. QATAR FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 192. QATAR FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 193. QATAR FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. QATAR FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. QATAR FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 196. QATAR FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 197. FINLAND FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. FINLAND FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 199. FINLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 200. FINLAND FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 201. FINLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. FINLAND FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. FINLAND FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 204. FINLAND FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 220. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 221. EGYPT FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. EGYPT FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 223. EGYPT FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 224. EGYPT FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 225. EGYPT FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. EGYPT FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. EGYPT FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 228. EGYPT FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. TURKEY FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. TURKEY FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 231. TURKEY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 232. TURKEY FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 233. TURKEY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. TURKEY FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. TURKEY FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 236. TURKEY FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 245. NORWAY FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. NORWAY FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 247. NORWAY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 248. NORWAY FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 249. NORWAY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. NORWAY FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. NORWAY FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 252. NORWAY FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 253. POLAND FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. POLAND FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 255. POLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 256. POLAND FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 257. POLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. POLAND FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. POLAND FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 260. POLAND FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 278. CHINA FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. CHINA FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 280. CHINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 281. CHINA FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 282. CHINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. CHINA FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. CHINA FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 285. CHINA FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 286. INDIA FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. INDIA FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 288. INDIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 289. INDIA FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 290. INDIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. INDIA FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. INDIA FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 293. INDIA FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 294. JAPAN FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. JAPAN FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 296. JAPAN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 297. JAPAN FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 298. JAPAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. JAPAN FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. JAPAN FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 301. JAPAN FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 309. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 317. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 325. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 326. THAILAND FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 327. THAILAND FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 328. THAILAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 329. THAILAND FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 330. THAILAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. THAILAND FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 332. THAILAND FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 333. THAILAND FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY TREATMENT AREA, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 340. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY APPLICATION METHOD, 2018-2030 (USD MILLION)
TABLE 341. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 343. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2030 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Facial Injectables market report include:
  • AbbVie Inc.
  • Galderma S.A.
  • Merz Pharma GmbH & Co. KGaA
  • Ipsen S.A.
  • Revance Therapeutics, Inc.
  • Evolus, Inc.
  • Daewoong Pharmaceutical Co., Ltd.
  • Medytox Inc.
  • Hugel, Inc.
  • Suneva Medical, Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 21.63 Billion
Forecasted Market Value ( USD ) by 2030 $ 37.76 Billion
Compound Annual Growth Rate11.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Aesthetic Injectables Market by Product Type, Mode of Administration, Application, End-User - Global Forecast to 2030 - Product Image

Aesthetic Injectables Market by Product Type, Mode of Administration, Application, End-User - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen & PMMA Microspheres, HA), By Application (Facial Line Correction, Lip Augmentation), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen & PMMA Microspheres, HA), By Application (Facial Line Correction, Lip Augmentation), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Facial Injectables Market Report by Product Type, Application Type, Application, End User, and Region 2024-2032 - Product Image

Facial Injectables Market Report by Product Type, Application Type, Application, End User, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Facial Injectables - Global Strategic Business Report - Product Image

Facial Injectables - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Facial Injectable Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Facial Injectable Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.